VOYA Investment Management
JUNO

VOYA Investment Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

VOYA Investment Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-18,479
Closed -$845K – 2609
2017
Q4 		$845K Buy
18,479
+680
+4% +$33.9K ﹤0.01% 1522
2017
Q3 		$798K Hold
17,799
– – ﹤0.01% 1573
2017
Q2 		$532K Sell
17,799
-7,288
-29% -$180K ﹤0.01% 1784
2017
Q1 		$557K Sell
25,087
-1,157
-4% -$24.8K ﹤0.01% 1658
2016
Q4 		$495K Sell
26,244
-1,167
-4% -$28.6K ﹤0.01% 1740
2016
Q3 		$823 Buy
27,411
+855
+3% +$26.6K ﹤0.01% 1430
2016
Q2 		$1.02M Buy
+26,556
New +$1.1M ﹤0.01% 1264
2016
Q1 		– Sell
-5,281
Closed -$232K – 2540
2015
Q4 		$232K Sell
5,281
-260
-5% -$12.9K ﹤0.01% 2206
2015
Q3 		$225K Buy
5,541
+54
+1% +$2.37K ﹤0.01% 2212
2015
Q2 		$293K Buy
5,487
+716
+15% +$38K ﹤0.01% 2282
2015
Q1 		$289K Buy
+4,771
New +$232K ﹤0.01% 2251

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

VOYA Investment Management's JUNO Position: Q1 2018 in Review

VOYA Investment Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 18,479 shares — an estimated $845K sold.

VOYA Investment Management first reported a position in JUNO in Q1 2015 and held it in 11 quarters. The position peaked at $1.02M in Q2 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • VOYA Investment Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • VOYA Investment Management sold 18,479 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $845K.
  • VOYA Investment Management first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
  • VOYA Investment Management's Juno Therapeutics, Inc. position peaked at $1.02M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on VOYA Investment Management's 13F filing for Q1 2018, filed 15 May 2018.